Experts in labelling and artwork management solutions
Kallik is a global provider of labelling and artwork management solutions for regulated markets such as the pharmaceutical, medical devices, cosmetics and chemicals industries.
Our solutions offer global organisations a platform to manage and transform their global messaging, in print and online, in a controlled, transparent and compliant way.
Kallik was established in 2001. Our flagship labelling content management and automated artwork generation platform was devised based on the founders’ in-depth experience in this field, and today underpins the businesses of companies including: Acelity, BSN medical, Cardinal Health, Coloplast, Diversey, ExxonMobil, Integra, Mary Kay, NBTY, Nikwax, Teleflex and Unilever.
In August 2019, Kallik was bought out by FPE Capital LLP (‘FPE’), a leading UK growth equity investor in specialist technology companies offering differentiated products or services that are critical to their customers. FPE plans to accelerate the company’s growth through strengthening the team and building further on the existing sector credentials. John Hawkins, an experienced software executive and former Chair of FPE investment Kallidus, has joined the Board as Non-Executive Chairman. David Bennett, former Head of Sales at Zinc Ahead, a high-growth compliance SaaS provider to the pharmaceutical industry, and previously employed within FPE’s portfolio joins the business as CRO at completion. You can read the press release about the investment here.
The Kallik Management team
The innovative qualities that mark out Kallik’s solutions are the direct result of our team’s deep knowledge and experience of our target markets.
David Bennett – Chief Revenue Officer
David Burton – Chief Financial Officer
Ashley Goldie – Chief Operating Officer
Dave Tarbuck – Client Success Director
Rob Woodall – Technical Director
Beth Peckover – Consulting Services Director